Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical tri…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
European Equities Traded in the US as American Depositary Receipts Decline Friday European equities traded in the US as American depositary receipts were lower on Friday morning, she | MMT Newswires | |
European Equities Traded in the US as American Depositary Receipts Higher Tuesday European equities traded in the US as American depositary receipts were rising Tuesday morning, up 1 | MMT Newswires | |
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business Genenta Science SPA (NASDAQ:GNTA) is among the best Italian stocks to buy in 2026. Genenta Science SPA (NASDAQ:GNTA) will hold an extraordinary shareholders meeting on March 26. This comes on the back of the company announcing a major shift in its business strategy. Genenta Science, which has all along been concentrating on biotech programs with […] | IInsider Monkey | |
European Equities Traded in the US as American Depositary Receipts Gain Friday European equities traded in the US as American depositary receipts were rising on Friday morning, up | MMT Newswires | |
US-China Trade Optimism Lifts US Equity Futures Pre-Bell US equity futures were up ahead of Monday's opening bell as traders monitored developments surroundi | MMT Newswires | |
Genenta Science (GNTA): Assessing Valuation After Expanded Anemocyte Partnership Spurs Industry Optimism Genenta Science (NasdaqCM:GNTA) recently drew widespread attention after announcing an expanded partnership with Anemocyte, centered on advancing off-the-shelf lentiviral vector Plasmid DNA technology. This move highlights growing confidence in Genenta’s research trajectory. See our latest analysis for Genenta Science. Genenta Science's share price soared this week following the expanded Anemocyte collaboration, locking in a remarkable 1-day share price return of 91.95% and a 7-day return... | ||
Genenta Science And 2 Other Penny Stocks To Consider As the U.S. stock market shows resilience amidst big bank earnings and ongoing trade tensions with China, investors continue to seek opportunities across various sectors. Penny stocks, though often seen as a relic of past trading days, remain a relevant investment area due to their potential for growth at lower price points. These smaller or newer companies can offer significant upside when they have strong financials and fundamentals, making them an intriguing option for those looking to... | ||